CELLDEX THERAPEUTICS
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
CELLDEX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1983-01-01
Address:
Hampton, New Jersey, United States
Country:
United States
Website Url:
http://www.celldex.com
Total Employee:
101+
Status:
Active
Contact:
(800) 736-3001
Email Addresses:
[email protected]
Total Funding:
875 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Windtree Therapeutics
Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
OmniAb
Therapeutic antibody discovery
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-11-01 | Kolltan Pharmaceuticals | Kolltan Pharmaceuticals acquired by Celldex Therapeutics | 235 M USD |
| 2009-10-01 | Curagen Corporation | Curagen Corporation acquired by Celldex Therapeutics | N/A |
| 2005-11-01 | Lorantis | Lorantis acquired by Celldex Therapeutics | N/A |
| 2005-10-12 | Alteris Therapeutics | Alteris Therapeutics acquired by Celldex Therapeutics | N/A |
Official Site Inspections
http://www.celldex.com Semrush global rank: 2.45 M Semrush visits lastest month: 7.26 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Celldex Therapeutics"
About Us - Celldex Therapeutics
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. ... a leading Massachusetts managed care …See details»
Celldex Therapeutics
Celldex is always looking for passionate and talented individuals to join our team. Learn More. [email protected]. 53 Frontage Road Suite 220 Hampton NJ 08827 (908) 454-7120. 300 …See details»
Celldex Therapeutics - Crunchbase Company Profile & Funding
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are …See details»
Investor & Media Home | Celldex Therapeutics
Mar 4, 2025 Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available …See details»
Celldex Therapeutics - Funding, Financials, Valuation & Investors
Nov 1, 2016 Celldex is a clinical stage company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases. New. Resources. ... Which types of …See details»
Celldex Therapeutics - The Org
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment …See details»
Celldex Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Celldex Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 76 clinical trials, 122 news, and 242 literature, Disease Domain:Neoplasms, Hemic and …See details»
Contact Us - Celldex Therapeutics
300 George Street Suite 530 New Haven, CT 06511 (203) 483-3500. 151 Martine Street Fall River, MA 02723See details»
Celldex Therapeutics - Contacts, Employees, Board Members, …
Organization. Celldex Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of …See details»
Celldex Therapeutics (CLDX) Company Profile & Description
Mar 10, 2008 Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other …See details»
Celldex Therapeutics Company Overview, Contact Details
Feb 29, 2024 Clinical Stages Success Celldex Therapeutics has showcased success in developing monoclonal and bispecific antibodies for devastating diseases, with recent positive …See details»
Celldex Reports Fourth Quarter and Year End 2024 Financial …
Dec 31, 2024 Celldex’s first bispecific for inflammatory diseases, CDX-622, Phase 1 study initiated Multiple important data read outs anticipated in 2025 HAMPTON, N.J. , Feb. 27, 2025 …See details»
Celldex Therapeutics - Craft
Oct 29, 2024 Celldex Therapeutics has 5 employees across 4 locations and $6.88 m in annual revenue in FY 2023. See insights on Celldex Therapeutics including office locations, …See details»
Celldex Therapeutics - Overview, News & Similar companies
May 6, 2024 Celldex Therapeutics contact info: Phone number: (908) 200-7500 Website: www.celldex.com What does Celldex Therapeutics do? Founded in 1983, Celldex …See details»
Celldex Announces Two New Appointments to its Board of Directors
HAMPTON, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that it has appointed Cheryl L. Cohen and Dr. Garry Neil …See details»
Cheryl L. Cohen - Celldex Therapeutics
Ms. Cohen has been a director of Celldex since June 2022. Ms. Cohen has served as President of CLC Consulting, a pharmaceutical and biotechnology consulting firm that specializes in new …See details»
Celldex Therapeutics Inc. Company & People | CLDX | Barron's
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the …See details»
Celldex Therapeutics to Present at Upcoming Investor Conferences
HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two …See details»
Careers - Celldex Therapeutics
Celldex is a great place to work; we have built an environment where innovative and talented people thrive—focusing a significant effort on attracting and retaining highly skilled and …See details»
Celldex a new overweight at Morgan Stanley on urticaria candidate
6 days ago Celldex's only other candidate in the clinic is the bispecific antibody CDX-622 in phase 1 for inflammation and fibrosis, though Frommer sees potential here as well.See details»